MTOR and melanoma: Therefore, based on the reports from the literature and our own promising results, we decided to investigate the effect of three generations of mTOR inhibitors in the combination with an inhibitor of the MAP kinase pathway (AS-703026) on the apoptosis process in melanoma cells.